Your browser doesn't support javascript.
loading
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Pertesi, Maroulio; Vallée, Maxime; Wei, Xiaomu; Revuelta, Maria V; Galia, Perrine; Demangel, Delphine; Oliver, Javier; Foll, Matthieu; Chen, Siwei; Perrial, Emeline; Garderet, Laurent; Corre, Jill; Leleu, Xavier; Boyle, Eileen M; Decaux, Olivier; Rodon, Philippe; Kolb, Brigitte; Slama, Borhane; Mineur, Philippe; Voog, Eric; Le Bris, Catherine; Fontan, Jean; Maigre, Michel; Beaumont, Marie; Azais, Isabelle; Sobol, Hagay; Vignon, Marguerite; Royer, Bruno; Perrot, Aurore; Fuzibet, Jean-Gabriel; Dorvaux, Véronique; Anglaret, Bruno; Cony-Makhoul, Pascale; Berthou, Christian; Desquesnes, Florence; Pegourie, Brigitte; Leyvraz, Serge; Mosser, Laurent; Frenkiel, Nicole; Augeul-Meunier, Karine; Leduc, Isabelle; Leyronnas, Cécile; Voillat, Laurent; Casassus, Philippe; Mathiot, Claire; Cheron, Nathalie; Paubelle, Etienne; Moreau, Philippe; Bignon, Yves-Jean; Joly, Bertrand.
Afiliación
  • Pertesi M; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.
  • Vallée M; Department of Laboratory Medicine, Division of Hematology and Transfusion medicine, Lund University, Lund, Sweden.
  • Wei X; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.
  • Revuelta MV; Biological Statistics and Computational Biology, Cornell University, Ithaca, NY, USA.
  • Galia P; Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Demangel D; ProfilExpert, Lyon, France.
  • Oliver J; Hospices Civils de Lyon, Lyon, France.
  • Foll M; ProfilExpert, Lyon, France.
  • Chen S; Hospices Civils de Lyon, Lyon, France.
  • Perrial E; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.
  • Garderet L; Medical Oncology Service, Hospitales Universitarios Regional y Virgen de la Victoria; Institute of Biomedical Research in Malaga (IBIMA), CIMES, University of Málaga, Málaga, Spain.
  • Corre J; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.
  • Leleu X; Biological Statistics and Computational Biology, Cornell University, Ithaca, NY, USA.
  • Boyle EM; INSERM 1052, CNRS 5286, CRCL, Lyon, France.
  • Decaux O; University of Lyon, Lyon, France.
  • Rodon P; INSERM, UMR_S 938, Paris, France.
  • Kolb B; AP-HP, Hôpital Saint Antoine, Departement d'hematologie et de therapie cellulaire, Paris, France.
  • Slama B; Sorbonne Universites, UPMC Univ Paris 06, UMR_S 938, Paris, France.
  • Mineur P; IUC-Oncopole and CRCT INSERM U1037, Toulouse, France.
  • Voog E; Inserm CIC 1402 & Service d'Hématologie et Thérapie Cellulaire, CHU La Miletrie, Poitiers, France.
  • Le Bris C; Hôpital Claude Huriez, CHRU, Lille, France.
  • Fontan J; Service de Medecine Interne, CHU Rennes, Rennes, France.
  • Maigre M; Faculte de Medecine, Universite de Rennes 1, Rennes, France.
  • Beaumont M; INSERM UMR U1236, Rennes, France.
  • Azais I; Unite d'Hematologie et d'Oncologie, Centre Hospitalier, Perigueux, France.
  • Sobol H; Hematologie Clinique, CHU de Reims, Reims, France.
  • Vignon M; Service d'Onco hematologie, CH Avignon, Avignon, France.
  • Royer B; Hematologie et pathologies de la coagulation, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Perrot A; Centre Jean Bernard, Institut Inter-regional de Cancerologie, Le Mans, France.
  • Fuzibet JG; Service post urgences, CHU de FORT DE FRANCE, pôle RASSUR, Martinique, France.
  • Dorvaux V; Hopital Jean Minjoz, CHRU Besançon, Besançon, France.
  • Anglaret B; Service d'Hemato-Oncologie, CHU Chartres, Chartres, France.
  • Cony-Makhoul P; Hematologie clinique et therapie cellulaire, CHU Amiens, Amiens, France.
  • Berthou C; Service de rhumatologie, CHU Poitiers, Poitiers, France.
  • Desquesnes F; Cancer Genetics Department, Paoli-Calmettes Institute, Aix-Marseille University, Marseille, France.
  • Pegourie B; Service d'Immuno-hematologie, Hôpital Saint Louis, Paris, France.
  • Leyvraz S; Service d'Immuno-hematologie, Hôpital Saint Louis, Paris, France.
  • Mosser L; Service d'Hematologie, CHU de Nancy, Universite de Lorraine, Vandoeuvre les Nancy, Nancy, France.
  • Frenkiel N; Internal Medicine Department, Archet Hospital, CHU Nice, Nice, France.
  • Augeul-Meunier K; Service d'Hematologie, CHR Mercy, Metz, France.
  • Leduc I; Unite d'Hematologie, CH Valence, Valence, France.
  • Leyronnas C; Service d'Hematologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France.
  • Voillat L; Service d'Hematologie, CHU de Brest, Brest, France.
  • Casassus P; Haematology Department, CHU UCL Namur, Yvoir, Belgium.
  • Mathiot C; Hematologie clinique, CHU de Grenoble, La Tronche, France.
  • Cheron N; Departement d'oncologie, CHUV, Lausanne, Switzerland.
  • Paubelle E; Unite d'oncologie medicale, Pôle medical 2, Hôpital Jacques Puel, Rodez, France.
  • Moreau P; CH Poissy, Saint-Germain-en-Laye, France.
  • Bignon YJ; Service Hematologie, Institut de Cancerologie Lucien Neuwirth, Saint-Priest-en-Jarez, France.
  • Joly B; Hematologie, CHG Abbeville, Abbeville, France.
Leukemia ; 33(9): 2324-2330, 2019 09.
Article en En | MEDLINE | ID: mdl-30967618
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mutación de Línea Germinal / Exoma / Complejo Multienzimático de Ribonucleasas del Exosoma / Mieloma Múltiple Límite: Female / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mutación de Línea Germinal / Exoma / Complejo Multienzimático de Ribonucleasas del Exosoma / Mieloma Múltiple Límite: Female / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia